Prostate News Archive
17-Jan-2009
Clarient Launches Gene Expression Test For Prostate Cancer (Medical News Today)
Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced the commercial launch of its new gene expression test for prostate cancer. Exploring Causes For Declining Prostate Cancer Mortality Rates In The United States (Medical News Today)
UroToday.com - A question that has never been clearly answered is, following the introduction of PSA screening in the US in 1989, why prostate cancer (CaP) deaths increased between 1989 and 1993, then decreased from 1993 to 2003. Eight-Year Experience Of HDR Brachytherapy Boost For Localized Prostate Cancer: Biopsy And PSA Outcome (Medical News Today)
UroToday.com - In 2004, we reported our observations on early toxicity in patients treated with an inversely planned high-dose rate (HDR) brachytherapy boost. In this study, we present our most recent observations on biochemical and pathological controls for patients with localized prostate cancer at intermediate and high risk of recurrence.
Back to Prostate News Archive
